Type 1 Diabetes
Conditions
Keywords
Type 1 Diabetes, 17 to 20 years of age
Brief summary
Structured transition program for adolescents and young adults with Type 1 Diabetes (T1D) improves diabetes clinic attendance as well as glycemic control after transition from pediatric to adult diabetes care.
Detailed description
The purpose of this study is to determine if a structured transition program for adolescents and young adults with Type 1 Diabetes (T1D) improves diabetes clinic attendance and management as well as glycemic control after transition from pediatric to adult diabetes care.
Interventions
OTHERTransition Coordinator
The Transition Coordinator is central to the intervention and will provide ongoing contact with the medical system as well as education and clinical support where appropriate.
Sponsors
Juvenile Diabetes Research Foundation
University of Western Ontario, Canada
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
17 Years to 20 Years
Healthy volunteers
No
Inclusion criteria
* Established T1D diagnosis for a minimum of one year (chosen to allow time for adjustment to a new diagnosis and more stable disease control). * Between the ages of 17 and 20 years. It is left to the clinical judgment of the pediatric endocrinologist to determine individually the appropriate age of the transition for each subject * At least 1 visit during the previous year with the pediatric endocrinologist at a Diabetes Clinic (aim is to minimize the non-adherence with the intervention). * Ability to participate in all aspects of this clinical trial. * Written informed consent/assent must be obtained and documented. * Resident of Ontario.
Exclusion criteria
* Pregnant or lactating females or intent to become pregnant during the next 3 years. * Conditions which in the opinion of the investigator may interfere with the subject's ability to participate in the study. * Prior enrollment in the current study. * Current participation in another clinical trial or participation in another clinical trial in the 6 months prior to enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of subjects who fail to attend at least one outpatient adult endocrinology visit during the second year after transition to adult diabetes care. | 30 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| In the 2 year transfer to adult care-Frequency of A1C (glycated hemoglobin test) | 30 months | In the 2 year transfer to adult care-Frequency of A1C (glycated hemoglobin test) & mean levels Frequency of retinal exam microalbumin to creatinine ratio fasting lipid profile and foot exam testing Rate of hospitalization/ER visits for acute complications of diabetes |
Countries
Canada
Outcome results
None listed